OzenYOzbayMBErtemAGYaylaÇ. Serum electrolyte levels and ventricular arrhythmia. Angiology. 2019;70(1):87–8.
2.
KayaAKeskinMTatlisuMAKayapinarO. Effect of dynamic potassium change on in-hospital mortality, ventricular arrhythmias, and long-term mortality in STEMI. Angiology. 2019;70(1):69–77.
3.
UluganyanMEkmekçiAMuratA. Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction. Anatolian J Cardiol. 2016;16(1):10–5.
4.
KeskinMKayaATatlisuMA. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J Cardiol. 2016;221:505–10.
PurvisJRMovahedA. Magnesium disorders and cardiovascular diseases. Clin Cardiol. 1992;15(8):556–8.
7.
SheehanJPSeeligMS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium. 1984;3(4-6):301–14.
8.
WhangRRyderKW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA. 1990;263(22):3063–4.
9.
ValgimigliMBuenoHByrneRA. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2017;53(1):34–78.
10.
DanzigerJWilliamJHScottDJ. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83(4):692–9.
